Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 603-689-1 | 3-(2-{4-[(Z)-(2,4-DIFLUOROPHENYL)(HYDROXYIMINO)METHYL]PIPERIDIN-1-YL}ETHYL)-2-METHYL-6,7,8,9-TETRAHYDRO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | 132961-05-8 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 3 | H301 | H301 |
GHS08 GHS06 Dgr |
State/Form
|
1 |  |
View details | ||||
| Skin Sens. 1B | H317 | H317 | |||||||||
| STOT RE 2 | H373 (other:central n...) | H373 | |||||||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
| H302 |
GHS07 Wng |
1 | View details | ||||||||
| Acute Tox. 3 | H301 | H301 |
GHS08 GHS07 GHS06 Dgr |
1 | View details | ||||||
| Skin Sens. 1 | H317 | H317 | |||||||||
| STOT RE 2 | H373 (not specified) (oral) | H373 | |||||||||
| Aquatic Chronic 3 | H412 | H412 | |||||||||
Number of Aggregated Notifications: 3